Medochemie and the Research and
Innovation Foundation have signed a contract for its production.
The
contract for the innovation project INNOVATE / 0719/0083 was signed by the
Director of Research, Development and Innovation of Medochemie,
Dr. Christakis
Sergides and the General Director of the Research and Innovation Foundation,
Theodoros Loukaidis. The INNOVATE / 0719/0083 project was selected for funding
under the program "Development and Promotion of Internationally
Competitive Innovative Products and Services by Existing Companies - RESTART
2016-2020". The aim of the project is to produce an innovative new
generation drug, an achievement which is expected to raise the Cypriot pharmaceutical
industry high on the map of global innovation, in the field of research and
development.
Dr. Christakis
Sergides, stated that the implementation of the innovative research proposal,
which is activated with the signing of the contract, is of utmost importance,
as it is expected to offer better and cheaper treatment, while improving the
quality of life of people suffering from severe gastrointestinal disorders.
He
even pointed out that the seven expert evaluators of the research proposal
considered it as a global innovation, both the production of this drug and the
way it will be transported and act in the large intestine. The active ingredient of the drug, said Mr. Sergides,
will be released in a slow controlled way that will increase the time of local
residence and action in the intestine, contributing to the treatment of
inflammatory diseases, such as IBD (Crohn's disease and ulcerative colitis).
AroundThe active ingredient of the
drug, said Mr. Sergidis, will be released in a slow controlled way that will
increase the time of local residence and action in the intestine, contributing
to the treatment of inflammatory diseases, such as IBD (Crohn's disease and
ulcerative colitis).
Το δραστικό συστατικό του φαρμάκου, δήλωσε ο κ.
Σεργίδης, θα απελευθερωθεί με αργό ελεγχόμενο τρόπο που θα αυξήσει τον χρόνο
τοπικής διαμονής και δράσης στο έντερο, συμβάλλοντας στη θεραπεία φλεγμονωδών
ασθενειών, όπως η IBD (νόσος του Crohn και ελκώδης) κωλίτης).
The active drug component, said features the main
Sergides will be released at a slow controlled manner which increases the time
of local residence and action in the intestine, contributing to the treatment
of inflammatory diseases such as IBD (Crohn's disease and ulcerative colitis).
Το δραστικό συστατικό του φαρμάκου, τα εν λόγω
χαρακτηριστικά, τα κύρια Sergides θα απελευθερωθούν με αργό ελεγχόμενο τρόπο, ο
οποίος αυξάνει τον χρόνο τοπικής παραμονής και δράσης στο έντερο, συμβάλλοντας
στη θεραπεία φλεγμονωδών ασθενειών όπως η IBD (νόσος του Crohn και ελκώδης
κολίτιδα).
Can't load full results
Try again
Retrying...
Retrying...
Around 3
million people in Europe and 1.5 million in the United States are suffering
from IBD, which has recently been found to be widespread in Asia.
The
Chief Scientist and Chairman of the Board of Directors of the Research and
Innovation Foundation, Dr. Nikolas Mastroyiannopoulos, welcomed the signing of
the financing contract for the project, which was selected through a highly
competitive process, emphasizing its importance in the health sector. Dr.
Mastroyiannopoulos also stated that the innovative activity of Cypriot
companies, such as that of Medochemie, is particularly important in the effort
to achieve the strategic goal, to make research and innovation as a basis for
sustainable development of our country.
Αs he characteristically stated, both he and all the
competent bodies remain committed to actions, with the aim of consolidating the
conditions. This
will allow the construction of a modern, efficient and competitive innovation ecosystem,
which will bring added value and socio-economic benefits In fact, as he characteristically stated,
both he and all the competent bodies, remain committed to actions, with the aim
of consolidating the conditions that will allow the construction of a modern,
efficient and competitive ecosystem, which will bring added value and
socio-economic benefits.
Στην πραγματικότητα, όπως είπε χαρακτηριστικά, τόσο
αυτός όσο και όλοι οι αρμόδιοι φορείς, παραμένουν δεσμευμένοι σε δράσεις, με
στόχο την ενοποίηση των συνθηκών που θα επιτρέψουν την κατασκευή ενός
σύγχρονου, αποτελεσματικού και ανταγωνιστικού οικοσυστήματος, το οποίο θα φέρει
προστιθέμενη αξία και κοινωνικο- οικονομικά οφέλη.
Indeed, as he said, both he and all the competent
institutions remain committed to actions aimed at establishing the conditions
that will allow the building of a modern, efficient and competitive ecosystem,
which will bring added value and socio-economic benefits
Πράγματι, όπως είπε, τόσο αυτός όσο και όλοι οι
αρμόδιοι φορείς παραμένουν δεσμευμένοι σε δράσεις που αποσκοπούν στον καθορισμό
των συνθηκών που θα επιτρέψουν την οικοδόμηση ενός σύγχρονου, αποτελεσματικού
και ανταγωνιστικού οικοσυστήματος, το οποίο θα αποφέρει προστιθέμενη αξία και
κοινωνικοοικονομικά οφέλη.
Can't load full results
Try again
Retrying...
Retrying...
in
our country.
Dr.
Christakis Sergides also mentioned that at Medochemie we innovate in order to
offer a better quality of life to our fellow humans:
-
We invest
more than 3% of our turnover in the field of Research, Development and
Innovation
-
With our pharmaceutical
products we improve the quality of life of around 300 million people in 107
countries
-
We
promote the health of people in Cyprus and abroad through the 630 different
pharmaceutical products, classified in over than 10 therapeutic categories, which
are produced in our 13 state-of-the-art production facilities
Can't load full results
Try again
Retrying...
Retrying...
in our country.
...
Can't load full results
Try again
Retrying...
Retrying...
Can't load full results
Try again
Retrying...
Retrying...
Some 3 million people in Europe and 1.5 million in
the United States are suffering from IBD, which has recently been found to be
widespread in Asia.
Περίπου 3 εκατομμύρια άνθρωποι στην Ευρώπη και 1,5 εκατομμύρια στις Ηνωμένες Πολιτείες πάσχουν από IBD, το οποίο πρόσφατα διαπιστώθηκε ότι είναι διαδεδομένο στην Ασία.
Approximately 3 million people in Europe and 1.5
million people in the United States suffer with IBD recently found to spread
significantly in Asia.
Περίπου 3 εκατομμύρια άνθρωποι στην Ευρώπη και 1,5 εκατομμύρια άνθρωποι στις Ηνωμένες Πολιτείες υποφέρουν με το IBD που βρέθηκε πρόσφατα να εξαπλώνεται σημαντικά στην Ασία.
Can't load full results
Try again
Retrying...
Retrying
He even pointed out that the seven expert evaluators
of the research proposal considered as a global innovation, both the production
of this drug and the way it will be transported and act in the large intestine.
Τόνισε ακόμη ότι οι επτά εμπειρογνώμονες αξιολογητές της ερευνητικής πρότασης θεωρούνταν ως παγκόσμια καινοτομία, τόσο την παραγωγή αυτού του φαρμάκου όσο και τον τρόπο μεταφοράς του και δράσης στο παχύ έντερο.
He suggested that the seven experts evaluators of the
research proposal considered as a global innovation, the production of this pharmaceutical
preparation, and the way they moved and will act in the colon.
Πρότεινε ότι οι επτά εμπειρογνώμονες αξιολογητές της ερευνητικής πρότασης θεωρούνται ως παγκόσμια καινοτομία, η παραγωγή αυτού του φαρμακευτικού παρασκευάσματος και ο τρόπος με τον οποίο κινούνται και θα ενεργούν στο παχύ έντερο.
Can't load full results
Try again
Retrying...
Retryin
Christakis Sergidis, stated that the implementation
of the Research proposal, which is activated with the signing of the contract,
is of utmost importance, as it is expected to offer better and cheaper
treatment, while improving the quality of life of people suffering from severe
gastrointestinal disorders.
Ο Χριστάκης Σεργίδης, δήλωσε ότι η εφαρμογή της
ερευνητικής πρότασης, η οποία ενεργοποιείται με την υπογραφή της σύμβασης,
είναι ύψιστης σημασίας, καθώς αναμένεται να προσφέρει καλύτερη και φθηνότερη
θεραπεία, βελτιώνοντας παράλληλα την ποιότητα ζωής των ατόμων που πάσχουν από
σοβαρό γαστρεντερικό. διαταραχές.
Christakis Sergides said that the implementation of
the Research proposal, triggered by the signing of the contract is paramount,
as it is expected to offer better and cheaper treatment, while improving the
quality of life of people suffering from severe gastrointestinal disorders.
Ο Χριστάκης Σεργίδης είπε ότι η υλοποίηση της
πρότασης έρευνας, που προκλήθηκε από την υπογραφή της σύμβασης, είναι ύψιστης
σημασίας, καθώς αναμένεται να προσφέρει καλύτερη και φθηνότερη θεραπεία,
βελτιώνοντας παράλληλα την ποιότητα ζωής των ανθρώπων που πάσχουν από σοβαρές
γαστρεντερικές διαταραχές.
Can't load full results
Try again
Retrying...
Retrying...
